Payment overview · 2025
General Payments
$646.15
39 reported records · 11 companies
Healthcare provider profile · identity verified
Mark J Samson, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · DUBLIN, GA · NPI 1386637189
Verified facts
What the public records show
CMS Open Payments records show Mark J Samson, M.D. received $646.15 in general payments during 2025 across 39 reported records.
Amgen Inc. accounted for 22.3% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 19 associated products.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 31 claims for Synthroid by this doctor in 2024.
Astellas Pharma US Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Myrbetriq as an associated drug or biological on 16 records involving 16 distinct recipient NPIs. Public Medicare Part D data also shows 70 claims for Myrbetriq by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 98 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 29 claims for Symbicort by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 213 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 29 claims for Paxlovid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Amgen Inc. | Unresolved — no canonical attribution shown | $144.32 | 22.3% | 13 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $119.53 | 18.5% | 7 | 2025 |
| Astellas Pharma US Inc | Unresolved — no canonical attribution shown | $85.06 | 13.2% | 5 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $66.60 | 10.3% | 3 | 2025 |
| Philips North America LLC | Unresolved — no canonical attribution shown | $54.49 | 8.4% | 2 | 2025 |
| Seqirus USA Inc | Unresolved — no canonical attribution shown | $47.94 | 7.4% | 2 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $44.22 | 6.8% | 2 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $30.15 | 4.7% | 2 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $19.53 | 3.0% | 1 | 2025 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | Unresolved — no canonical attribution shown | $18.98 | 2.9% | 1 | 2025 |
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $15.33 | 2.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $646.15 | 39 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $131.65 | 12 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $131.36 | 12 | 2025 |
Source payment records
|
|||||
| Veozah Normalized: veozah |
Drug | Astellas Pharma US Inc | $85.06 | 5 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $70.00 | 4 | 2025 |
Source payment records
|
|||||
| ZAVZPRET Normalized: zavzpret |
Drug | PFIZER INC. | $70.00 | 4 | 2025 |
Source payment records
|
|||||
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $66.60 | 3 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $66.60 | 3 | 2025 |
Source payment records
|
|||||
| ECC Solutions Normalized: ecc solutions |
Device | Philips North America LLC | $54.49 | 2 | 2025 |
Source payment records
|
|||||
| Fluad Normalized: fluad |
Biological | Seqirus USA Inc | $47.94 | 2 | 2025 |
Source payment records
|
|||||
| Flucelvax Normalized: flucelvax |
Biological | Seqirus USA Inc | $47.94 | 2 | 2025 |
Source payment records
|
|||||
| AIRSUPRA Normalized: airsupra |
Drug | AstraZeneca Pharmaceuticals LP | $44.22 | 2 | 2025 |
Source payment records
|
|||||
| ABRYSVO Normalized: abrysvo |
Biological | PFIZER INC. | $34.08 | 2 | 2025 |
Source payment records
|
|||||
| COMIRNATY Normalized: comirnaty |
Biological | PFIZER INC. | $34.08 | 2 | 2025 |
Source payment records
|
|||||
| PREVNAR 20 Normalized: prevnar 20 |
Biological | PFIZER INC. | $34.08 | 2 | 2025 |
Source payment records
|
|||||
| FREESTYLE LIBRE Normalized: freestyle libre |
Device | Abbott Laboratories | $30.15 | 2 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC | $19.53 | 1 | 2025 |
Source payment records
|
|||||
| XIFAXAN Normalized: xifaxan |
Drug | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.98 | 1 | 2025 |
Source payment records
|
|||||
| VYNDAMAX Normalized: vyndamax |
Drug | PFIZER INC. | $15.45 | 1 | 2025 |
Source payment records
|
|||||
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $15.33 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
31 | suppressed by CMS |
| Astellas Pharma US Inc Exact reporting entity; no affiliate inference |
2025 | Myrbetriq open payments reported associated product |
CMS Open Payments — General Payments 16 supporting records · 16 recipient NPIs · example record 1238599014 |
Myrbetriq · 2024 Exact normalized brand match · 1 Part D row |
70 | 14 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
98 | 19 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
29 | suppressed by CMS |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
213 | 43 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | PAXLOVID open payments reported associated product |
CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432 |
Paxlovid · 2024 Exact normalized brand match · 1 Part D row |
29 | 29 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1111 | 271 |
| Amlodipine Besylate | Amlodipine Besylate | 762 | 181 |
| Levothyroxine Sodium | Levothyroxine Sodium | 681 | 145 |
| Lisinopril | Lisinopril | 562 | 133 |
| Gabapentin | Gabapentin | 550 | 150 |
| Pantoprazole Sodium | Pantoprazole Sodium | 546 | 142 |
| Losartan Potassium | Losartan Potassium | 433 | 108 |
| Montelukast Sodium | Montelukast Sodium | 430 | 112 |
| Metoprolol Succinate | Metoprolol Succinate | 393 | 93 |
| Metformin Hcl Er | Metformin Hcl | 354 | 90 |
| Duloxetine Hcl | Duloxetine Hcl | 333 | 67 |
| Omeprazole | Omeprazole | 314 | 73 |
| Metoprolol Tartrate | Metoprolol Tartrate | 296 | 75 |
| Pravastatin Sodium | Pravastatin Sodium | 282 | 69 |
| Tamsulosin Hcl | Tamsulosin Hcl | 281 | 72 |
| Metformin Hcl | Metformin Hcl | 280 | 67 |
| Carvedilol | Carvedilol | 272 | 68 |
| Clopidogrel | Clopidogrel Bisulfate | 271 | 71 |
| Potassium Chloride | Potassium Chloride | 269 | 56 |
| Allopurinol | Allopurinol | 267 | 65 |
| Fluticasone Propionate | Fluticasone Propionate | 267 | 129 |
| Jardiance | Empagliflozin | 267 | 44 |
| Valsartan | Valsartan | 246 | 52 |
| Furosemide | Furosemide | 240 | 65 |
| Tramadol Hcl | Tramadol Hcl | 233 | 59 |
| Eliquis | Apixaban | 213 | 43 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 209 | 63 |
| Sertraline Hcl | Sertraline Hcl | 206 | 45 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 205 | 70 |
| Meloxicam | Meloxicam | 203 | 67 |
| Tizanidine Hcl | Tizanidine Hcl | 201 | 53 |
| Simvastatin | Simvastatin | 189 | 52 |
| Hydralazine Hcl | Hydralazine Hcl | 187 | 37 |
| Escitalopram Oxalate | Escitalopram Oxalate | 186 | 39 |
| Ozempic | Semaglutide | 179 | 23 |
| Hydrochlorothiazide | Hydrochlorothiazide | 170 | 55 |
| Trazodone Hcl | Trazodone Hcl | 167 | 44 |
| Famotidine | Famotidine | 147 | 42 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 146 | 37 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 131 | 28 |
| Mirtazapine | Mirtazapine | 123 | 30 |
| Colchicine | Colchicine | 117 | 51 |
| Zolpidem Tartrate | Zolpidem Tartrate | 113 | 21 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 112 | 25 |
| Donepezil Hcl | Donepezil Hcl | 108 | 19 |
| Nifedipine Er | Nifedipine | 107 | 29 |
| Rybelsus | Semaglutide | 107 | 20 |
| Diclofenac Sodium | Diclofenac Sodium | 104 | 36 |
| Citalopram Hbr | Citalopram Hydrobromide | 102 | 27 |
| Doxazosin Mesylate | Doxazosin Mesylate | 102 | 25 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 100 | 30 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 100 | 14 |
| Farxiga | Dapagliflozin Propanediol | 98 | 19 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 97 | 25 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 97 | 65 |
| Alprazolam | Alprazolam | 90 | 21 |
| Amoxicillin | Amoxicillin | 89 | 71 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 87 | 23 |
| Pregabalin | Pregabalin | 87 | 20 |
| Sucralfate | Sucralfate | 87 | 27 |
| Ezetimibe | Ezetimibe | 85 | 26 |
| Amitriptyline Hcl | Amitriptyline Hcl | 84 | 19 |
| Finasteride | Finasteride | 83 | 20 |
| Atenolol | Atenolol | 82 | 22 |
| Spironolactone | Spironolactone | 82 | 21 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 76 | 26 |
| Buspirone Hcl | Buspirone Hcl | 72 | 20 |
| Myrbetriq | Mirabegron | 70 | 14 |
| Clonidine Hcl | Clonidine Hcl | 68 | 19 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 68 | 20 |
| Fluoxetine Hcl | Fluoxetine Hcl | 68 | 20 |
| Fluconazole | Fluconazole | 65 | 49 |
| Methylprednisolone | Methylprednisolone | 65 | 63 |
| Glipizide | Glipizide | 64 | 15 |
| Pioglitazone Hcl | Pioglitazone Hcl | 64 | 14 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 64 | 11 |
| Meclizine Hcl | Meclizine Hcl | 62 | 27 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 60 | 28 |
| Oxybutynin Chloride | Oxybutynin Chloride | 60 | 12 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 59 | 11 |
| Clonazepam | Clonazepam | 59 | 14 |
| Baclofen | Baclofen | 57 | 19 |
| Glimepiride | Glimepiride | 57 | 14 |
| Desloratadine | Desloratadine | 56 | 19 |
| Ondansetron Odt | Ondansetron | 56 | 31 |
| Quetiapine Fumarate | Quetiapine Fumarate | 56 | 13 |
| Warfarin Sodium | Warfarin Sodium | 55 | suppressed |
| Bupropion Xl | Bupropion Hcl | 51 | 13 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 48 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 48 | 46 |
| Nystatin | Nystatin | 48 | 26 |
| Lovastatin | Lovastatin | 47 | 14 |
| Mounjaro | Tirzepatide | 47 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 46 | 18 |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 45 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 45 | 40 |
| Mupirocin | Mupirocin | 45 | 33 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 44 | 15 |
| Ropinirole Hcl | Ropinirole Hcl | 44 | 13 |
| Benazepril Hcl | Benazepril Hcl | 43 | 12 |
| Candesartan Cilexetil | Candesartan Cilexetil | 43 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 43 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 43 | 16 |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 42 | 15 |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 42 | suppressed |
| Levetiracetam | Levetiracetam | 42 | suppressed |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 42 | suppressed |
| Azithromycin | Azithromycin | 41 | 36 |
| Memantine Hcl | Memantine Hcl | 41 | 11 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 41 | 33 |
| Valacyclovir | Valacyclovir Hcl | 41 | 22 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 40 | suppressed |
| Temazepam | Temazepam | 40 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 39 | 15 |
| Januvia | Sitagliptin Phosphate | 39 | suppressed |
| Xarelto | Rivaroxaban | 39 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 38 | 11 |
| Candesartan-Hydrochlorothiazid | Candesartan/Hydrochlorothiazid | 38 | suppressed |
| Eszopiclone | Eszopiclone | 38 | suppressed |
| Glyxambi | Empagliflozin/Linagliptin | 38 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 37 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 36 | 23 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 36 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 35 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 34 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 34 | 24 |
| Celecoxib | Celecoxib | 33 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 33 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 33 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 33 | 13 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 32 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 32 | 12 |
| Entresto | Sacubitril/Valsartan | 31 | suppressed |
| Irbesartan | Irbesartan | 31 | suppressed |
| Synthroid | Levothyroxine Sodium | 31 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 30 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 30 | 24 |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 30 | suppressed |
| Telmisartan | Telmisartan | 30 | suppressed |
| Trulicity | Dulaglutide | 30 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 29 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 29 | 29 |
| Symbicort | Budesonide/Formoterol Fumarate | 29 | suppressed |
| Bumetanide | Bumetanide | 28 | suppressed |
| Lorazepam | Lorazepam | 28 | 18 |
| Spiriva Respimat | Tiotropium Bromide | 28 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 27 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 27 | suppressed |
| Nitroglycerin | Nitroglycerin | 27 | 15 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 27 | suppressed |
| Dutasteride | Dutasteride | 26 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 26 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 26 | suppressed |
| Topiramate | Topiramate | 26 | suppressed |
| Aripiprazole | Aripiprazole | 25 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 25 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 25 | suppressed |
| Methocarbamol | Methocarbamol | 25 | suppressed |
| Flunisolide | Flunisolide | 24 | 14 |
| Glipizide Er | Glipizide | 24 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 24 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 24 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 23 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 23 | 19 |
| Colesevelam Hcl | Colesevelam Hcl | 23 | suppressed |
| Cefadroxil | Cefadroxil | 22 | 21 |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 22 | 17 |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 22 | 11 |
| Silodosin | Silodosin | 22 | suppressed |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 21 | suppressed |
| Metronidazole | Metronidazole | 21 | 19 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 21 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 20 | suppressed |
| Ibuprofen | Ibuprofen | 20 | 11 |
| Ketoconazole | Ketoconazole | 20 | 17 |
| Novolog Flexpen | Insulin Aspart | 20 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 19 | suppressed |
| Ranolazine Er | Ranolazine | 19 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 19 | suppressed |
| Alcohol Pads | Alcohol Antiseptic Pads | 18 | suppressed |
| Carisoprodol | Carisoprodol | 18 | suppressed |
| Cephalexin | Cephalexin | 18 | 14 |
| Diltiazem 24hr Er | Diltiazem Hcl | 18 | suppressed |
| Estradiol | Estradiol | 18 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 18 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 18 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 17 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 17 | 15 |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 17 | suppressed |
| Risperidone | Risperidone | 17 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 17 | 11 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 16 | 16 |
| Arnuity Ellipta | Fluticasone Furoate | 16 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 16 | suppressed |
| Humalog | Insulin Lispro | 16 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 16 | suppressed |
| Pioglitazone-Glimepiride | Pioglitazone Hcl/Glimepiride | 16 | suppressed |
| Prasugrel Hcl | Prasugrel Hcl | 16 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 16 | 12 |
| Sulfasalazine | Sulfasalazine | 16 | suppressed |
| Torsemide | Torsemide | 16 | suppressed |
| Creon | Lipase/Protease/Amylase | 15 | suppressed |
| Lamotrigine | Lamotrigine | 15 | suppressed |
| Linzess | Linaclotide | 15 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 15 | suppressed |
| Prednisone | Prednisone | 15 | 12 |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 15 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 14 | suppressed |
| Diclofenac Sodium-Misoprostol | Diclofenac Sodium/Misoprostol | 14 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 14 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 14 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 14 | suppressed |
| Acyclovir | Acyclovir | 13 | suppressed |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 13 | suppressed |
| Levemir Flexpen | Insulin Detemir | 13 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 13 | suppressed |
| Novolin N Flexpen | Insulin Nph Human Isophane | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Verapamil Er Pm | Verapamil Hcl | 13 | suppressed |
| Calcitriol | Calcitriol | 12 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 12 | suppressed |
| Klor-Con M20 | Potassium Chloride | 12 | suppressed |
| Mesalamine | Mesalamine | 12 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 12 | suppressed |
| Sotalol | Sotalol Hcl | 12 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 12 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 12 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Tradjenta | Linagliptin | 12 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 12 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Fenofibrate | Fenofibrate | 11 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 11 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 11 | suppressed |
| Methimazole | Methimazole | 11 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 11 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 11 | suppressed |
| Tegretol Xr | Carbamazepine | 11 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $646.15 · 39 records | Amgen Inc. | ABRYSVO, AIRSUPRA, COMIRNATY, Dexcom G6 Transmitter, ECC Solutions, FREESTYLE LIBRE, Fluad, Flucelvax, NURTEC ODT, OTEZLA, PREVNAR 20, QULIPTA, REPATHA, REXULTI, UBRELVY, VYNDAMAX, Veozah, XIFAXAN, ZAVZPRET | 8 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error